Soleus Capital Management, L.P. Ani Pharmaceuticals Inc Transaction History
Soleus Capital Management, L.P.
- $1.29 Billion
- Q2 2025
A detailed history of Soleus Capital Management, L.P. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 50,743 shares of ANIP stock, worth $4.83 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
50,743
Previous 224,684
77.42%
Holding current value
$4.83 Million
Previous $15 Million
77.99%
% of portfolio
0.26%
Previous 1.24%
Shares
4 transactions
Others Institutions Holding ANIP
# of Institutions
243Shares Held
20MCall Options Held
19.9KPut Options Held
12.8K-
Black Rock Inc. New York, NY2.66MShares$253 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$122 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$95.6 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$82.1 Million3.45% of portfolio
-
State Street Corp Boston, MA716KShares$68.2 Million0.0% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.66B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...